Long-term Study With Clevudine

Summary

A open-labeled phase lV study with 96 weeks of treatment period. The purpose of this study is to investigate safety and efficacy of clevudine in patients chronically infected with hepatitis B virus, HBeAg positive or negative.

Timeline

Start

2007-06

Primary completion

2011-09

Completion

2011-09

Drugs

Indications